Hepatitis B virus infection and transfusion medicine: science and the occult
暂无分享,去创建一个
[1] J. Tanaka,et al. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C , 2007, Transfusion.
[2] W. Gerlich,et al. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus , 2007, Journal of viral hepatitis.
[3] F. Hollinger. Hepatitis B virus genetic diversity and its impact on diagnostic assays , 2007, Journal of viral hepatitis.
[4] E. Vamvakas,et al. Hepatitis B virus DNA–positive, hepatitis B surface antigen–negative blood donations intercepted by anti‐hepatitis B core antigen testing: the Canadian Blood Services experience , 2007, Transfusion.
[5] K. Nelson,et al. Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand , 2007, Transfusion.
[6] J. Laroche,et al. Detection and characterization of hepatitis B virus of anti‐hepatitis B core antigen–reactive blood donors in Quebec with an in‐house nucleic acid testing assay , 2007, Transfusion.
[7] L. Overby,et al. Serodiagnosis of Recent Hepatitis B Infection by IgM Class Anti‐HBc , 2007, Hepatology.
[8] T. Merigan,et al. Antiviral Treatment of Chronic Hepatitis B Virus Infection: Infectious Virus Cannot Be Detected in Patient Serum after Permanent Responses to Treatment , 2007, Hepatology.
[9] M. Satake,et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program , 2007, Transfusion.
[10] K. Tadokoro,et al. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen–negative) infection in the acute stage , 2007, Transfusion.
[11] J. Allain. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti‐HBc screening , 2007, Vox sanguinis.
[12] L. Finelli,et al. Surveillance for acute viral hepatitis--United States, 2005. , 2007, Morbidity and mortality weekly report. Surveillance summaries.
[13] M. Raptopoulou-Gigi,et al. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece. , 2007, Journal of gastrointestinal and liver diseases : JGLD.
[14] Z. Ullah,et al. Anti–hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice , 2007, Transfusion.
[15] T. Wright,et al. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy , 2007, Journal of viral hepatitis.
[16] J. Koskinas,et al. Natural History of Chronic Hepatitis B Virus Infection in Children of Different Ethnic Origins: A Cohort Study with Up to 12 Years' Follow-up in Northern Greece , 2007, Journal of pediatric gastroenterology and nutrition.
[17] J. Allain,et al. Characterization of HBV DNA+/HBsAg− blood donors in Poland identified by triplex NAT , 2006, Hepatology.
[18] K. Tadokoro,et al. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion , 2006, Transfusion.
[19] A. Duseja,et al. Prolonged Hepatitis B surface antigen positivity in Hepatitis B vaccine recipients. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[20] P. Lachenbruch,et al. Quantification of hepatitis B virus genomes and infectivity in human serum samples , 2006, Transfusion.
[21] J. Koskinas,et al. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients , 2006, Hepatology.
[22] C. Trautwein,et al. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). , 2006, Journal of hepatology.
[23] D. Thabut,et al. Immune Suppression as the Etiology of Failure To Detect Anti-HBc Antibodies in Patients with Chronic Hepatitis B Virus Infection , 2006, Journal of Clinical Microbiology.
[24] J. Tanaka,et al. Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[25] Ding‐Shinn Chen,et al. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[26] S. Kleinman,et al. Assessing the impact of HBV NAT on window period reduction and residual risk. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[27] W. Gerlich. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[28] M. Lazarini,et al. HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[29] B. Portmann,et al. Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression , 2006, International journal of STD & AIDS.
[30] Fangjun Zhou,et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. , 2005, International journal of epidemiology.
[31] J. Koskinas,et al. Natural history of chronic HBV infection: A cohort study with up to 12 years follow‐up in North Greece (part of the Interreg I‐II/EC‐project) , 2005, Journal of medical virology.
[32] P. Holland,et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test , 2005, Transfusion.
[33] W. Au,et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. , 2005, Journal of hepatology.
[34] K. Nishioka,et al. Hepatitis B NAT virus‐positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA , 2005 .
[35] Tomasz P. Michalak,et al. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection , 2004, Hepatology.
[36] S. Glynn,et al. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti‐HBc: implications for future HBV screening policy , 2004, Transfusion.
[37] C. Gibbs,et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. , 2004, Gastroenterology.
[38] K. Kleesiek,et al. Low‐level viraemia of hepatitis B virus in an anti‐HBc‐ and anti‐HBs‐positive blood donor , 2004, Transfusion medicine.
[39] Joseph D. C. Yao,et al. Multicenter Evaluation of the VERSANT Hepatitis B Virus DNA 3.0 Assay , 2004, Journal of Clinical Microbiology.
[40] J. Allain,et al. Occult hepatitis B virus infection: implications in transfusion , 2004, Vox sanguinis.
[41] W. Gerlich,et al. Transmission of Hepatitis B Virus 2 Months Prior to Hepatitis Surface Antigen Positivity of Donor Blood , 2003, Transfusion Medicine and Hemotherapy.
[42] F. Otaǧ. False positive HBsAg result in blood donors due to administration of three different recombinant DNA Hepatitis B vaccines. , 2003, Vaccine.
[43] K. Nishioka,et al. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. , 2003, Journal of virological methods.
[44] J. Molina,et al. Reactivation of HBV replication in HIV-HBV infected patients. , 2003, The American journal of medicine.
[45] G. Schreiber,et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection , 2003, Transfusion.
[46] S. Glynn,et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening , 2003, Transfusion.
[47] H. Kiyokawa,et al. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening , 2003, Vox sanguinis.
[48] S. M. Rogers,et al. LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value , 2003, Sexually transmitted infections.
[49] A. R. Davis,et al. Transient hepatitis B surface antigenemia in a blood donor after a combination hepatitis A and B vaccine , 2003, Transfusion.
[50] Ding‐Shinn Chen,et al. Transfusion‐transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers , 2002, Transfusion.
[51] J. Barbara,et al. Transfusion‐transmitted hepatitis B virus infection in the UK: a small and moving target , 2002, Vox sanguinis.
[52] H. Kirchner,et al. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. , 2002, Blood.
[53] G. Galea,et al. Hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen‐positive blood donors , 2002, Vox sanguinis.
[54] B. McMahon,et al. Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.
[55] O. Ural,et al. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. , 2001, The Journal of infection.
[56] S. Cameron,et al. Hepatitis B virus transmission by blood donation negative for hepatitis B surface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA , 2001, Vox sanguinis.
[57] W. Owiredu,et al. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D , 2001, Journal of medical virology.
[58] E. Sabino,et al. Significance of isolated hepatitis B core antibody in blood donors from São Paulo. , 2001, Revista do Instituto de Medicina Tropical de Sao Paulo.
[59] C. Bréchot,et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”? , 2001, Hepatology.
[60] A. Prince,et al. Infectivity of blood from PCR‐positive, HBsAg‐negative, anti‐HBs‐positive cases of resolved hepatitis B infection , 2001, Transfusion.
[61] J. Córdoba,et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti‐HBc positivity in the donor population , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[62] A. Heath,et al. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques , 2001, Vox sanguinis.
[63] B. McMahon,et al. Hepatitis B virions isolated with antibodies to the pre‐S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted , 2000, Transfusion.
[64] V. Carreño,et al. Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands. , 2000, Journal of hepatology.
[65] W. Jilg,et al. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. , 2000, The Journal of general virology.
[66] Y. Cheng,et al. Detection of IgM to hepatitis B core antigen in a reductant containing, chemiluminescence assay. , 1999, Journal of immunological methods.
[67] Yuan Wang,et al. Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen , 1999, Journal of Gastroenterology.
[68] R. Tedder,et al. Evidence that anti‐HBc but not HBV DNA testing may prevent some HBV transmission by transfusion , 1999, British journal of haematology.
[69] Tomasz P. Michalak,et al. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. , 1999, The Journal of clinical investigation.
[70] W. Gerlich,et al. Quantitative Detection of Hepatitis B Virus DNA in Two International Reference Plasma Preparations , 1999, Journal of Clinical Microbiology.
[71] P. Vereerstraeten,et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. , 1998, Transplantation.
[72] H. Ozen,et al. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels. , 1998, The Turkish journal of pediatrics.
[73] K. Koike,et al. Persistent viremia after recovery from self‐limited acute hepatitis B , 1998, Hepatology.
[74] Ding‐Shinn Chen,et al. Hepatitis B Virus Infection , 2007 .
[75] R. Wiesner,et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. , 1997, Gastroenterology.
[76] F. Chisari,et al. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.
[77] F. Chisari,et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. , 1996, The Journal of clinical investigation.
[78] M A Nowak,et al. Viral dynamics in hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[79] W. Ng,et al. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs. , 1996, Singapore medical journal.
[80] H. Schätzl,et al. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. , 1995, Journal of hepatology.
[81] B. Grossman,et al. Hepatitis B surface antigenemia in blood donors following vaccination , 1995, Transfusion.
[82] L. Mimms,et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients , 1995, Transfusion.
[83] B. Wegmüller,et al. Reliability of PCR decontamination systems. , 1994, PCR methods and applications.
[84] J. Fukushima,et al. Portal hypertension in schistosomiasis: A long‐term follow‐up of a randomized trial comparing three types of surgery , 1994, Hepatology.
[85] H. Okamoto,et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen , 1994, Journal of virology.
[86] J. Villeneuve,et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. , 1994, Gastroenterology.
[87] J. Wands,et al. Properties of hepatitis B virus pre-S1 deletion mutants. , 1994, Virology.
[88] L. Mimms,et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. , 1993, BMJ.
[89] P. Holland,et al. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine , 1993, Transfusion.
[90] A. Widell,et al. Hepatitis B virus DNA in serum and liver is commonly found in chinese patients with chronic liver disease despite the presence of antibodies to HBsAg , 1993, Hepatology.
[91] G. Meucci,et al. The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers , 1993, Annals of Internal Medicine.
[92] H. Okamoto,et al. Correlation between Anti‐HBc Titers and HBV DNA in Blood Units without Detectable HBsAg , 1992, Vox sanguinis.
[93] D. Sackett,et al. The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.
[94] G. Nimmo,et al. Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? , 1992, Australian and New Zealand journal of medicine.
[95] M. Yoshiba,et al. Post-transfusion fulminant hepatitis B after screening for hepatitis B virus core antibody , 1992, The Lancet.
[96] N. Brown,et al. Hepatitis B virus infection in patients with idiopathic liver disease , 1991, Hepatology.
[97] P. Tiollais,et al. Hepatitis B virus. , 1991, Scientific American.
[98] L. Mimms,et al. Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay , 1991, Journal of clinical microbiology.
[99] P. Holland,et al. Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen , 1991, Journal of clinical microbiology.
[100] D. Ganem,et al. The role of envelope proteins in hepatitis B virus assembly. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[101] R. Purcell,et al. 19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage , 1990, Infection.
[102] S. Kashiwagi,et al. Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan , 1990, Gastroenterologia Japonica.
[103] J. Wands,et al. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers , 1990, Hepatology.
[104] G. Gerken,et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. , 1990, The New England journal of medicine.
[105] G. Hetland,et al. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen‐negative hepatitis B virus carrier , 1990, Transfusion.
[106] S. Kwok,et al. Avoiding false positives with PCR , 1989, Nature.
[107] C. Bréchot,et al. TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTS , 1988, The Lancet.
[108] A. Czaja,et al. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. , 1987, Gastroenterology.
[109] M. Shapiro,et al. Determining the size of non-A, non-B hepatitis virus by filtration. , 1987, The Journal of infectious diseases.
[110] R. Purcell,et al. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. , 1987, Gastroenterology.
[111] B. Yvonnet,et al. Age‐ and sex‐related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal) , 1987, Journal of medical virology.
[112] E. Schiff,et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. , 1987, The New England journal of medicine.
[113] A. Blei,et al. Clinical significance of concurrent hepatitis B surface antigen and antibody positivity , 1986, Digestive Diseases and Sciences.
[114] T R Bender,et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. , 1985, The Journal of infectious diseases.
[115] F. Gyorkey,et al. Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate. , 1984, The Journal of infectious diseases.
[116] P. Hurlen,et al. Hepatitis B serum markers and oral health in a group of Norwegian male prisoners. , 1984, Acta odontologica Scandinavica.
[117] L. Hwang,et al. PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINE , 1983, The Lancet.
[118] S. Lemon,et al. Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus. , 1983, The Journal of infectious diseases.
[119] W. Szmuness,et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. , 1982, The Journal of infectious diseases.
[120] P. Dubreuil,et al. False Reactions in Radioimmunoassay for Viral Hepatitis B Markers in Patients Suffering from Coagulation Disorders , 1982, Vox sanguinis.
[121] H. Polesky,et al. Interpretation of various serological profiles of hepatitis B virus infection. , 1981, American journal of clinical pathology.
[122] R. Brouwer,et al. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study. , 1980, Journal of virological methods.
[123] W. Gerlich,et al. Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen. , 1980, The Journal of infectious diseases.
[124] J. Hoofnagle,et al. Hepatitis A and B virus markers in immune serum globulin , 1980 .
[125] J. Melnick,et al. Hbc ag, anti-HBC, and DNA polymerase activity in transfused recipients followed prospectively. , 1975, The American journal of the medical sciences.
[126] J. Weiler,et al. Risk of transfusing blood containing antibody to hepatitis-B surface antigen. , 1974, Lancet.
[127] K. Nishioka,et al. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. , 2005, Vox sanguinis.
[128] M. Alter,et al. Epidemiology of hepatitis B in Europe and worldwide. , 2003, Journal of hepatology.
[129] J. Wands,et al. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. , 1994, Journal of hepatology.
[130] P. Grob,et al. Detection of HBs antigen in "anti-HBc alone" positive sera. , 1994, Journal of hepatology.
[131] F. Chisari,et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. , 1994, The Journal of clinical investigation.
[132] D. Ganem,et al. Assembly of hepadnaviral virions and subviral particles. , 1991, Current topics in microbiology and immunology.
[133] A. Lok,et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. , 1991 .
[134] F. Tsuda,et al. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. , 1984, Gastroenterology.
[135] J. van Hattum,et al. Co‐occurrence of HBsAg and anti‐HBs: Two consecutive infections or a sign of advanced chronic liver disease? , 1982, Journal of medical virology.
[136] J. Allen. Post-transfusion hepatitis, a serious clinical problem. , 1966, California medicine.